SCHEMBL1069572

SCHEMBL1069572

Cc1cc(C)c([PH](=O)c2ccccc2)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2A6 P11509 1/20 0.38
TSHR P16473 3/20 0.35
LMNA P02545 2/20 0.35
ALOX12 P18054 1/20 0.35
ACHE P22303 1/20 0.35
NR3C1 P04150 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 1/20 0.33
RECQL P46063 1/20 0.33
METAP2 P50579 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MCOLN3 Q8TDD5 1/20 0.33
C5AR1 P21730 1/20 0.33
PSMB5 P28074 1/20 0.33
MEN1 O00255 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C19 P33261 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1377101 0.82 ACHE (0.41) FFAR4CYP1A2CYP2A6TSHRLMNA
SCHEMBL23466362 0.80 FFAR4 (0.42) FFAR4LMNAACHEALDH1A1SMN1; SMN2
SCHEMBL27187028 0.80 ALOX5 (0.44) FFAR4LMNAL3MBTL1ALDH1A1MEN1
SCHEMBL544371 0.79 RAPGEF4 (0.39) FFAR4CYP1A2CYP2A6TSHRLMNA
SCHEMBL22061738 0.77 FFAR4 (0.39) FFAR4CYP1A2CYP2A6TSHRLMNA
SCHEMBL22829710 0.77 MAPT (0.37) FFAR4CYP1A2CYP2A6LMNAACHE
SCHEMBL28301910 0.77 KDM4E (0.41) CYP1A2LMNAACHEL3MBTL1ALDH1A1
SCHEMBL25797874 0.76 HPGD (0.39) FFAR4CYP2A6TSHRALOX12ALDH1A1
SCHEMBL30657025 0.76 HPGD (0.39) FFAR4CYP2A6TSHRALOX12ALDH1A1
Toluene SCHEMBL27845318 0.75 ACHE (0.58) TSHRLMNAALOX12ACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504850-A Chiral phosphonamide compound and application thereof in serving as or preparing agricultural bacteriostat 贵州大学 2025-02-25 CN disclosed
EP-3844115-B1 ADDITIVE MANUFACTURING PHASE SEPARATING COMPOSITIONS TO PREPARE GLASSES AND CERAMICS ETH ZUERICH (CH) 2023-11-01 EP disclosed
US-20230212204-A1 REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS THE SCRIPPS RESEARCH INSTITUTE 2023-07-06 US disclosed
CN-110872321-B Diaryl phosphine oxide compound containing substituent group and preparation method thereof 山东科技大学 2021-05-25 CN disclosed
US-20210139720-A1 3D POLYMERIZABLE CERAMIC INKS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) 2021-05-13 US disclosed
CN-110872321-A Diaryl phosphine oxide compound containing substituent group and preparation method thereof 山东科技大学 2020-03-10 CN disclosed
US-10175436-B2 Optical fiber ribbons and ribbon matrix materials having low oligomer content Corning Optical Communications LLC (US) 2019-01-08 US disclosed
US-20180251645-A1 3D POLYMERIZABLE CERAMIC INKS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) 2018-09-06 US disclosed
EP-3337863-A1 3D POLYMERIZABLE CERAMIC INKS Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. (IL) 2018-06-27 EP disclosed
WO-2017029673-A1 3D POLYMERIZABLE CERAMIC INKS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) 2017-02-23 WO disclosed
US-20160299305-A1 OPTICAL FIBER RIBBONS AND RIBBON MATRIX MATERIALS HAVING LOW OLIGOMER CONTENT CORNING CABLE SYSTEMS LLC 2016-10-13 US disclosed
CN-105392616-A Method for preparing reinforcing rib ASAMER BASALTIC FIBERS GMBH 2016-03-09 CN disclosed
CN-101809055-B Curable resin composition for molded bodies, molded body, and production method thereof NIPPON CATALYTIC CHEM IND 2013-10-23 CN disclosed
CN-101528845-B Sheet-formable monomer composition, thermally conductive sheet, and method for producing thermally conductive sheet 3M INNOVATIVE PROPERTIES CO 2012-05-30 CN disclosed
EP-2454623-A1 OPTICAL FIBER RIBBONS AND RIBBON MATRIX MATERIALS HAVING LOW OLIGOMER CONTENT Corning Cable Systems LLC (US) 2012-05-23 EP disclosed
US-20120106907-A1 OPTICAL FIBER RIBBONS AND RIBBON MATRIX MATERIALS HAVING LOW OLIGOMER CONTENT CORNING CABLE SYSTEMS LLC 2012-05-03 US disclosed
WO-2011008523-A1 OPTICAL FIBER RIBBONS AND RIBBON MATRIX MATERIALS HAVING LOW OLIGOMER CONTENT CORNING CABLE SYSTEMS LLC (US) 2011-01-20 WO disclosed
EP-2185621-A1 CURABLE RESIN COMPOSITION FOR MOLDED BODIES, MOLDED BODY, AND PRODUCTION METHOD THEREOF Nippon Shokubai Co., Ltd. (JP) 2010-05-19 EP disclosed
CN-101528845-A Sheet-formable monomer composition, thermally conductive sheet, and method for producing thermally conductive sheet 3M INNOVATIVE PROPERTIES CO (US) 2009-09-09 CN disclosed
WO-2009041711-A1 CURABLE RESIN COMPOSITION FOR MOLDED BODIES, MOLDED BODY, AND PRODUCTION METHOD THEREOF NIPPON SHOKUBAI CO., LTD. (JP) 2009-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212204-A1 REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS PNKP, POLL, RNGTT FFAR4 3232/4885CYP1A2 3705/4885CYP2A6 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.